![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 28, 21048-21054, July 14, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Cell Biology, The Lerner Research Institute,
Cleveland Clinic Foundation, Cleveland, Ohio 44195
A role of the copper protein ceruloplasmin (Cp)
in iron metabolism is suggested by its ferroxidase activity and by the
tissue iron overload in hereditary Cp deficiency patients. In addition, plasma Cp increases markedly in several conditions of anemia, e.g. iron deficiency, hemorrhage, renal failure, sickle
cell disease, pregnancy, and inflammation. However, little is known
about the cellular and molecular mechanism(s) involved. We have
reported that iron chelators increase Cp mRNA expression and
protein synthesis in human hepatocarcinoma HepG2 cells. Furthermore, we
have shown that the increase in Cp mRNA is due to increased rate of
transcription. We here report the results of new studies designed to
elucidate the molecular mechanism underlying transcriptional activation of Cp by iron deficiency. The 5'-flanking region of the
Cp gene was cloned from a human genomic library. A
4774-base pair segment of the Cp promoter/enhancer driving
a luciferase reporter was transfected into HepG2 or Hep3B cells. Iron
deficiency or hypoxia increased luciferase activity by 5-10-fold
compared with untreated cells. Examination of the sequence showed three
pairs of consensus hypoxia-responsive elements (HREs). Deletion and
mutation analysis showed that a single HRE was necessary and sufficient
for gene activation. The involvement of hypoxia-inducible factor-1
(HIF-1) was shown by gel-shift and supershift experiments that showed HIF-1
Role of Hypoxia-inducible Factor-1 in Transcriptional Activation
of Ceruloplasmin by Iron Deficiency*
and HIF-1
binding to a radiolabeled oligonucleotide
containing the Cp promoter HRE. Furthermore, iron
deficiency (and hypoxia) did not activate Cp gene
expression in Hepa c4 hepatoma cells deficient in HIF-1
, as shown
functionally by the inactivity of a transfected Cp
promoter-luciferase construct and by the failure of HIF-1 to bind the
Cp HRE in nuclear extracts from these cells. These results
are consistent with in vivo findings that iron deficiency increases plasma Cp and provides a molecular mechanism that may help to
understand these observations.
*
This work was supported by National Institutes of Health
Grant HL29582 (to P. L. F.) and by a Fellowship of the American Heart Association of Northeast Ohio (to C. K. M.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Cell Biology,
The Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid
Ave., Cleveland, OH 44195. Tel.: 216-444-8053; Fax: 216-444-9404;
E-mail: foxp@ccf.org.
This article has been cited by other articles:
![]() |
C. Dezfulian, N. Raat, S. Shiva, and M. T. Gladwin Role of the anion nitrite in ischemia-reperfusion cytoprotection and therapeutics Cardiovasc Res, July 15, 2007; 75(2): 327 - 338. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Prasad, A. Chandra, C. K. Mukhopadhyay, and R. Prasad Unexpected Link between Iron and Drug Resistance of Candida spp.: Iron Depletion Enhances Membrane Fluidity and Drug Diffusion, Leading to Drug-Susceptible Cells Antimicrob. Agents Chemother., November 1, 2006; 50(11): 3597 - 3606. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Ke and M. Costa Hypoxia-Inducible Factor-1 (HIF-1) Mol. Pharmacol., November 1, 2006; 70(5): 1469 - 1480. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Haque, V. Wang, D. A. Davis, Z.-M. Zheng, and R. Yarchoan Genetic Organization and Hypoxic Activation of the Kaposi's Sarcoma-Associated Herpesvirus ORF34-37 Gene Cluster J. Virol., July 15, 2006; 80(14): 7037 - 7051. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Litz and G. W. Krystal Imatinib inhibits c-Kit-induced hypoxia-inducible factor-1{alpha} activity and vascular endothelial growth factor expression in small cell lung cancer cells. Mol. Cancer Ther., June 1, 2006; 5(6): 1415 - 1422. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Wenger, D. P. Stiehl, and G. Camenisch Integration of Oxygen Signaling at the Consensus HRE Sci. Signal., October 18, 2005; 2005(306): re12 - re12. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Martin, T. Linden, D. M. Katschinski, F. Oehme, I. Flamme, C. K. Mukhopadhyay, K. Eckhardt, J. Troger, S. Barth, G. Camenisch, et al. Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation Blood, June 15, 2005; 105(12): 4613 - 4619. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Hong, J. Ryu, and K. H. Han Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A Blood, February 15, 2005; 105(4): 1405 - 1407. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Acker and H. Acker Cellular oxygen sensing need in CNS function: physiological and pathological implications J. Exp. Biol., August 15, 2004; 207(18): 3171 - 3188. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Lee, H.-W. Lo, R.-P. Shao, S.-C. Wang, W. Xia, D. M. Gershenson, and M.-C. Hung Selective Activation of Ceruloplasmin Promoter in Ovarian Tumors: Potential Use for Gene Therapy Cancer Res., March 1, 2004; 64(5): 1788 - 1793. [Abstract] [Full Text] [PDF] |
||||
![]() |
K J Livesey, V L C Wimhurst, K Carter, M Worwood, E Cadet, J Rochette, A G Roberts, J J Pointon, A T Merryweather-Clarke, M L Bassett, et al. The 16189 variant of mitochondrial DNA occurs more frequently in C282Y homozygotes with haemochromatosis than those without iron loading J. Med. Genet., January 1, 2004; 41(1): 6 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sarkar, V. Seshadri, N. A. Tripoulas, M. E. Ketterer, and P. L. Fox Role of Ceruloplasmin in Macrophage Iron Efflux during Hypoxia J. Biol. Chem., November 7, 2003; 278(45): 44018 - 44024. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Schneider and E. A. Leibold Effects of iron regulatory protein regulation on iron homeostasis during hypoxia Blood, November 1, 2003; 102(9): 3404 - 3411. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Luhe, H. Hildebrand, U. Bach, T. Dingermann, and H.-J. Ahr A New Approach to Studying Ochratoxin A (OTA)-Induced Nephrotoxicity: Expression Profiling in Vivo and in Vitro Employing cDNA Microarrays Toxicol. Sci., June 1, 2003; 73(2): 315 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hofer, R. H. Wenger, M. F. Kramer, G. C. Ferreira, and M. Gassmann Hypoxic up-regulation of erythroid 5-aminolevulinate synthase Blood, January 1, 2003; 101(1): 348 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. N. J. Strube, J. L. Beard, and A. C. Ross Iron Deficiency and Marginal Vitamin A Deficiency Affect Growth, Hematological Indices and the Regulation of Iron Metabolism Genes in Rats J. Nutr., December 1, 2002; 132(12): 3607 - 3615. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Miyazaki, T. Kawamoto, K. Tanimoto, M. Nishiyama, H. Honda, and Y. Kato Identification of Functional Hypoxia Response Elements in the Promoter Region of the DEC1 and DEC2 Genes J. Biol. Chem., November 27, 2002; 277(49): 47014 - 47021. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. WENGER Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression FASEB J, August 1, 2002; 16(10): 1151 - 1162. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Seshadri, P. L. Fox, and C. K. Mukhopadhyay Dual Role of Insulin in Transcriptional Regulation of the Acute Phase Reactant Ceruloplasmin J. Biol. Chem., July 26, 2002; 277(31): 27903 - 27911. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tran, M. Ashraf, L. Jones, T. Westbrook, M. Hazegh-Azam, and M. C. Linder Dietary Iron Status Has Little Effect on Expression of Ceruloplasmin but Alters That of Ferritin in Rats J. Nutr., March 1, 2002; 132(3): 351 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Roy and C. A. Enns Iron homeostasis: new tales from the crypt Blood, December 15, 2000; 96(13): 4020 - 4027. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Huffman, A. Mokashi, H. P. Bachinger, and R. G. Brennan The Basic Helix-Loop-Helix Domain of the Aryl Hydrocarbon Receptor Nuclear Transporter (ARNT) Can Oligomerize and Bind E-box DNA Specifically J. Biol. Chem., October 26, 2001; 276(44): 40537 - 40544. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |